Clinical Trials Browser

Withdrawn × Infliximab × Clear all

NCT06646016 2025-12-26

EPIC

Phase 2 Withdrawn

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02763761 2018-10-09

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Phase 2 Withdrawn

DermatologicGenitourinaryThoracic

Carcinoma, Renal Cell, Lung Neoplasms, Melanoma

NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome